S udden, unexpected cardiac arrest is a major threat to the patient who has advanced heart failure and accounts for approximately half of all deaths in this population.12 Therapy with diuretics and vasodilators frequently produces substantial improvement in heart failure symptoms and functional status, even in patients with severely depressed ventricular function.3 However, as therapy for the congestive symptoms of heart failure has improved, prevention of sudden cardiac arrest has emerged as a major challenge in the management of the heart failure patient. Numerous studies of cardiac arrest victims and survivors of aborted cardiac arrests have identified several potential causes of cardiac arrest, the most common of which is ventricular tachycardia (VT) or fibrillation (VF) due to either acute ischemia or reentry in a healed myocardial scar. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] These studies have focused primarily on the patient with coronary artery disease, including patients with and without heart failure, and may not accurately indicate the frequency of various causes of death in the heart failure population. Heart failure is associated with activation of the sympathetic nervous system and electrolyte abnormalities that could affect arrhythmogenesis.122,24 In addition, heart failure patients are predisposed to systemic and venous thromboemboli that could precipitate cardiac arrest. 25 Establishing the causes of cardiac arrest in heart failure patients is important for the development of therapeutic strategies to reduce sudden death in this population. Therefore, we reviewed clinical and autopsy data from all electrocardiographically monitored, sudden, unexpected cardiac arrests observed during a 4-year period in hospitalized patients with advanced but stable heart failure.
Methods
Records of all patients admitted to the UCLA Medical Center under the care of the Heart Failure Service from 1984 to 1988 were reviewed. Patients were included in this study if they suffered an unexpected cardiac arrest during telemetry electrocardiographic monitoring in-hospital and if they met the following criteria: 1) The patient had New York Heart Association class III or IV heart failure before admission. 2) The patient was referred for evaluation for cardiac transplantation or adjustment of medical therapy and improved while on medical therapy such that in the absence of intravenous inotropic medications and ventricular assist devices the patient was clinically stable during the 48 hours preceding the arrest and hospital discharge was anticipated. Thus, decompensated heart failure was absent before arrest as evident from systolic blood pressure greater than 80 mm Hg and absence of rales or dyspnea at rest. 3) Clinical evidence of uncontrolled infection was absent before the arrest and at subsequent necropsy.
Of 284 consecutive patients admitted to the heart failure service, 216 were stabilized on medical therapy. An Nonischemic dilated cardiomyopathy. Nonischemic dilated cardiomyopathy required dilated heart failure with absence of obstructive coronary artery stenoses or other structural cause of heart failure determined by either coronary angiography or necropsy.
Statistical Analysis
Continuous data are shown as mean + 1 SD. Student's t test and Fisher's exact test were used for statistical comparisons.
Results
The clinical characteristics of the patient population are shown in Table 1 . Nineteen of the 20 patients had severely depressed systolic ventricular function (mean left ventricular ejection fraction, 0.18±0.08) and by study design were receiving chronic vasodilators (captopril or hydralazine and isosorbide dinitrate) and diuretics for heart failure.
Initial Cardiac Rhythm
The initial rhythm at the time of cardiac arrest was sinus bradycardia in nine (43%) arrests, secondor third-degree atrioventricular (AV) block in two (10%) arrests, EMD in two (10%) arrests, VT degenerating to VF in seven (33%) arrests, and VF in one (5%) arrest (Figure 1 ). Thus, eight (38%) arrests were due to VT or VF (VT/VF group) and 13 (62%) were due to a bradycardia arrest or EMD (BA/EMD group).
Patients in the VT/VF and BA/EMD groups are compared in Table 2 . All eight patients in the VT/VF group had coronary artery disease compared with only six of 13 patients in the BA/EMD group (p=0.02). No difference was found between groups in the likelihood of successful resuscitation, left ventricular ejection fraction, bundle branch block, first-degree AV block, serum potassium levels, or serum magnesium levels. Patients in the BA/EMD group had lower serum sodium concentrations than those in the VTNVF group. Four patients had a history of sustained VT, two of whom suffered BA and two of whom suffered VT/VF arrests. A history of nonsustained VT (>3 beats) during telemetry electrocardiographic moni- ,.
rhythm strips at the onset of cardiac arrest in patient 8. Sinus bradycardia with PR interval prolongation is competing with a slow junctional escape rhythm (top tracing). Sinus beats falling early after a junctional escape beat (after the fourth QRS from the left) are blocked in the atrioventricular conducting system above the ventricles. This was shortly followed by absence of sinus p waves and a junctional escape rhythm at 45 beats/mmn (lower tracing) that progressively slowed (not ishown).
She died suddenly at home 2 weeks later. An autopsy on the patient who died of AV block failed to reveal a precipitating cause for the arrest.
Both EMD arrests were fatal. One patient (patient 1) had a normally functioning permanent pacemaker. Autopsies revealed both pulmonary and coronary emboli in one patient and a fresh right coronary artery thrombosis overlying atherosclerotic plaque in the second patient. Thus, after BA/EMD arrest, five patients were resuscitated, and an autopsy was performed in six of the eight patients who had a fatal arrest. Of these 11 patients, cardiac arrest was attributed to an acute structural cause (coronary artery thromboemboli or pulmonary emboli) in three patients. Two patients had hyperkalemia, and one had hypoglycemia potentially contributing to the arrest. But in five of these 11 patients and in two others who had arrests in which an autopsy was not performed, no precipitating factor for BA could be established.
Etiology of Ventricular Tachycardia and Ventricular Fibrillation
Four of the 8 patients with VT/VF arrests were resuscitated. One (patient 13) had serum enzyme evidence of acute myocardial infarction. He suffered a fatal BA 3 weeks after the VT arrest. The remaining three survivors received antiarrhythmic medications. One received a cardiac transplant (patient 20), and one died suddenly at home (patient 18) within 2 weeks of initial arrest. The third patient is alive 3 years later without recurrent cardiac arrest (patient 19). Autopsies were performed in all four of the patients with fatal arrest. All had areas of old infarction, and one had evidence of a recent infarction (a few days old) that had not been suspected before death. One patient had hyperkalemia (6.3 meq/l) at the time of arrest. Thus, five arrests were attributed to a primary arrhythmia. Discussion Sudden, unexpected cardiac arrest is a major risk confronting the patient with advanced heart failure.1,2'26 Several studies have examined precipitating causes of cardiac arrest. These studies focused primarily on patients with coronary artery disease and included patients with and without heart failure. In out-of-hospital cardiac arrests, the initial cardiac rhythm was VF in approximately 60% of victims, VT in less than 10%, and bradycardia or asystole in the remaining 30%.4-7,17 However, fortuitously obtained ambulatory electrocardiographic recordings immediately preceding and during sudden cardiac arrests have shown VT degenerating to VF in more than 80% of arrests.18-22 Thus, VT degenerating to VF appears to be the mechanism of the arrest in the large majority of out-of-hospital sudden cardiac arrests. Studies of patients resuscitated from cardiac arrest4,7-11 and necropsy studies4,12-16 have suggested that the VT episode was due to either acute ischemia or reentry arising in an area of healed infarction.
The causes of sudden cardiac arrest in patients with advanced heart failure have not been specifically studied previously. The present study shows that the causes of cardiac arrest in heart failure are multifactorial. A primary ventricular arrhythmia accounted for only 38% of arrests. All VT arrests occurred in patients with prior myocardial infarction. In a prior study of patients with advanced heart failure, we found that programmed electric stimulation initiated sustained VT in 20% of patients who had a previous infarction but only in 6% of patients with heart failure in the absence of prior myocardial infarction.2 Although patients with heart failure in the absence of prior infarction do occasionally develop sustained VT,27 this is relatively uncommon compared with the coronary artery disease population. Thus, infarction may produce the appropriate substrate for reentrant arrhythmias more frequently than does nonischemic cardiomyopathy. Of the 15 patients with heart failure due to prior myocardial infarction, VT/VF was the mechanism of cardiac arrest in only eight (53%), fewer 
